# A Randomized Controlled Pilot Trial of Mesalazine in Patients With Irritable Bowel Syndrome

> **NCT00774007** · PHASE2,PHASE3 · COMPLETED · sponsor: **SOFAR S.p.A.** · enrollment: 20 (actual)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DRUG:** mesalazine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00774007
- **Lead sponsor:** SOFAR S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2008-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00774007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00774007, "A Randomized Controlled Pilot Trial of Mesalazine in Patients With Irritable Bowel Syndrome". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00774007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*